Document Detail


Orexin signaling via the orexin 1 receptor mediates operant responding for food reinforcement.
MedLine Citation:
PMID:  20189166     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Orexin (hypocretin) signaling is implicated in drug addiction and reward, but its role in feeding and food-motivated behavior remains unclear.
METHODS: We investigated orexin's contribution to food-reinforced instrumental responding using an orexin 1 receptor (Ox1r) antagonist, orexin -/- (OKO) and littermate wildtype (WT) mice, and RNAi-mediated knockdown of orexin. C57BL/6J (n = 76) and OKO (n = 39) mice were trained to nose poke for food under a variable ratio schedule of reinforcement. After responding stabilized, a progressive ratio schedule was initiated to evaluate motivation to obtain food reinforcement.
RESULTS: Blockade of Ox1r in C57BL/6J mice impaired performance under both the variable ratio and progressive ratio schedules of reinforcement, indicating impaired motivational processes. In contrast, OKO mice initially demonstrated a delay in acquisition but eventually achieved levels of responding similar to those observed in WT animals. Moreover, OKO mice did not differ from WT mice under a progressive ratio schedule, indicating delayed learning processes but no motivational impairments. Considering the differences between pharmacologic blockade of Ox1r and the OKO mice, animals with RNAi mediated knockdown of orexin were then generated and analyzed to eliminate possible developmental effects of missing orexin. Orexin gene knockdown in the lateral hypothalamus in C57BL/6J mice resulted in blunted performance under both the variable ratio and progressive ratio schedules, resembling data obtained following Ox1r antagonism.
CONCLUSIONS: The behavior seen in OKO mice likely reflects developmental compensation often seen in mutant animals. These data suggest that activation of the Ox1r is a necessary component of food-reinforced responding, motivation, or both in normal mice.
Authors:
Ruth Sharf; Maysa Sarhan; Catherine E Brayton; Douglas J Guarnieri; Jane R Taylor; Ralph J DiLeone
Related Documents :
12350286 - The effects of using stimuli from three different dimensions on autoshaping with a comp...
15222966 - Responding for sucrose and wheel-running reinforcement: effect of body weight manipulat...
17452296 - Influence of reinforcement schedule on ethanol consumption patterns in non-food restric...
8972546 - Progressive ratio and behavioral economic evaluation of the reinforcing efficacy of ora...
15961186 - The agouti-related protein and its role in energy homeostasis.
19711216 - Application of ftir and raman microspectroscopy to the study of food/packaging interact...
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't     Date:  2010-02-26
Journal Detail:
Title:  Biological psychiatry     Volume:  67     ISSN:  1873-2402     ISO Abbreviation:  Biol. Psychiatry     Publication Date:  2010 Apr 
Date Detail:
Created Date:  2010-04-05     Completed Date:  2010-06-17     Revised Date:  2014-09-13    
Medline Journal Info:
Nlm Unique ID:  0213264     Medline TA:  Biol Psychiatry     Country:  United States    
Other Details:
Languages:  eng     Pagination:  753-60     Citation Subset:  IM    
Copyright Information:
Copyright 2010 Society of Biological Psychiatry. Published by Elsevier Inc. All rights reserved.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Benzoxazoles / pharmacology
Conditioning, Operant / physiology*
Data Interpretation, Statistical
Food*
Hypothalamic Area, Lateral / physiology
Immunohistochemistry
Intracellular Signaling Peptides and Proteins / physiology*
Male
Mice
Mice, Inbred C57BL
Mice, Knockout
Motor Activity / drug effects
Neuropeptides / physiology*
Orexin Receptors
RNA Interference
Receptors, Neuropeptide / genetics*,  physiology*
Reinforcement (Psychology)
Reinforcement Schedule
Urea / analogs & derivatives,  pharmacology
Viruses / genetics
Grant Support
ID/Acronym/Agency:
F32DA023739/DA/NIDA NIH HHS; P50 MH066172/MH/NIMH NIH HHS; P50 MH066172-080003/MH/NIMH NIH HHS; R01 DA011717/DA/NIDA NIH HHS; R01 DA015222/DA/NIDA NIH HHS; R01 DA017676/DA/NIDA NIH HHS; R01 DA017676-05/DA/NIDA NIH HHS; R01DA017676/DA/NIDA NIH HHS; RL1AA017537/AA/NIAAA NIH HHS
Chemical
Reg. No./Substance:
0/1-(2-methylbenzoxazol-6-yl)-3-(1,5)naphthyridin-4-yl urea; 0/Benzoxazoles; 0/Intracellular Signaling Peptides and Proteins; 0/Neuropeptides; 0/OX1 protein, mouse; 0/Orexin Receptors; 0/Receptors, Neuropeptide; 0/orexins; 8W8T17847W/Urea
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Effects of the mGlu2/3 agonist LY379268 and the mGlu5 antagonist MTEP on ethanol seeking and reinfor...
Next Document:  Object affordance and spatial-compatibility effects in Parkinson's disease.